(Press-News.org) BOSTON – The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.
"For many decades it had been believed that a history of prostate cancer, even if treated and cured, was an absolute contraindication to testosterone therapy, due to the belief that testosterone activated prostate cancer growth, and could potentially cause dormant cancer cells to grow rapidly," says Abraham Morgentaler, MD of Men's Health Boston. "Generations of medical students and residents were taught that providing testosterone to a man with prostate cancer was like pouring gasoline on a fire."
This study, involving 13 symptomatic testosterone deficient men who also had untreated prostate cancer, suggests this traditional view is incorrect, and that testosterone treatment in men does not cause rapid growth of prostate cancer. It is the first to directly and rigorously assess changes in the prostate among men with prostate cancer who received testosterone therapy.
The men received testosterone therapy while undergoing active surveillance for prostate cancer for a median of 2.5 years. Median age was 58.8 years. The initial biopsy Gleason score was 6/10 for 12 of the men, 7/10 for the other (Gleason score grades the aggressiveness of prostate cancer by its microscopic appearance on a scale of 2-10. Gleason 6 is generally considered low to moderately aggressive, and Gleason 7 moderately aggressive).
Mean testosterone concentration increased from 238 to 664 ng/dl with treatment, yet neither prostate specific antigen (PSA) concentrations nor prostate volume showed any change. Follow-up biopsies of the prostate were performed in all men at approximately yearly intervals, and none developed cancer progression. In fact, 54 percent of the follow-up biopsies revealed no cancer at all.
Although the number of men in the study was small, and none had aggressive or advanced prostate cancer, Morgentaler observed, "These men were rigorously followed. The cancers in these men were typical of the prostate cancers for which men have undergone invasive treatment with surgery or radiation for 25 years. Clearly, the traditional belief that higher testosterone necessarily leads to rapid prostate cancer growth is incorrect."
In a Journal of Urology editorial comment, Martin M. Miner, MD, of the Miriam Hospital and Warren Alpert School of Medicine of Brown University notes the conclusions represent "a remarkable shift in thinking from only five years ago. … If testosterone therapy was not associated with disease progression in men with untreated prostate cancer, how concerned must we be about testosterone therapy in men with treated prostate cancer?"
"An increasing number of newly diagnosed men with prostate cancer opting for active surveillance, and with many of them also desiring treatment for their signs and symptoms of testosterone deficiency, the results suggest a reevaluation of the long standing prohibition against offering testosterone therapy to men with prostate cancer," says Morgentaler.
Refraining from testosterone therapy due to unmerited prostate cancer fears may have adverse lifestyle and health consequences, since testosterone therapy in testosterone deficient men has been shown to improve symptoms of fatigue, decreased libido, and erectile dysfunction. Testosterone therapy may also improve mood, blood sugar control, increase muscle, decrease fat, and improve bone density. Four recent studies have shown that men with high testosterone levels appear to live longer than men with low levels, although it has not yet been shown that treating men with testosterone increases longevity.
Morgentaler commented on an Italian study that showed that low levels of testosterone were associated with aggressive prostate cancer. The risk of aggressive cancer was reduced for men with normal testosterone compared with men with low testosterone.
In an editorial in the journal Cancer, "Turning Conventional Wisdom Upside Down: Low Serum Testosterone and High-Risk Prostate Cancer Morgentaler wrote, "After seven decades of circumstantial evidence pointing us in the wrong direction, perhaps it is time to consider the once unthinkable – conducting a testosterone therapy trial of sufficient size and duration to determine whether normalization of serum testosterone in older men many reduce the risk of prostate cancer, particularly high-risk prostate cancer."
INFORMATION:
In addition to Morgentaler, a member of the Division of Urology in the BIDMC Department of Surgery and an associate clinic professor of surgery at Harvard Medical School, the study was co-authored by Michael Sweeney, MD of Harvard Medical School and Larry I. Lipshultz, MD, Richard Bennett, MD, Desiderio Avila, Jr., MD, and Mohit Khera, MD, of Baylor Medical College.
The authors reported financial interests and/or other relationships with Auxilium Pharmaceuticals, Watson Pharmaceuticals, Slate Pharmaceuticals, Bayer Healthcare, GlaxoSmithKline, Solvay Pharmaceuticals, Pfizer Inc., Eli Lilly & Co., Allergan, Inc., American Medical Systems and Repros Therapeutics.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.
END
Breast implants appear to be associated with a rare form of lymphoma, but there is not yet evidence to show that the cancer is caused by implants or to suggest an underlying mechanism for how the disease might develop, according to a study by researchers from the RAND Corporation.
The study, published online by the journal Plastic and Reconstructive Surgery, also finds that the disease takes a slow course and can be controlled by surgical removal of the implant and surrounding capsule.
The conclusions are based on an exhaustive review of the medical literature regarding ...
CHAMPAIGN, Ill. — A repeat of a corporate tax holiday that found little success in stimulating the economy in 2005 is still a long-shot to jump-start a stagnant U.S. economy, says a University of Illinois expert in corporate and international taxation.
Dhammika Dharmapala, a professor of law at Illinois, says that while the idea of a tax holiday has found favor among some politicians and presidential hopefuls looking to jolt the country out of the financial doldrums, it would have little positive effect on economic growth.
"Ostensibly, the aim is to increase domestic ...
When a couple decides that it is time to end their marriage they face many challenges, not the least of which is dividing the marital property. While there are exceptions, marital property is generally defined as property that is acquired after the date of marriage and before a spouse files for divorce. This can include a house, vehicles, bank accounts, debts, retirement funds and business interest.
The division of marital property at times can be fairly straight forward and at other times very complex -- dividing a closely-held or family business is one of the most ...
Independent contractors are widely utilized in the construction business to help reduce costs and bring in valuable outside expertise. For employers, using independent contractors means employment tax savings and the avoidance of certain labor laws. But, problems arise when employers start calling regular employees "independent contractors."
Misclassified workers miss out on a number of benefits, including workers' compensation rights, unemployment insurance, and the ability to collectively bargain. In the construction industry, misclassification of employees ...
The BP Deepwater Horizon oil spill caused social disruption and psychological stress among Gulf residents that is similar to the aftermath of the Exxon Valdez spill and the impacts are likely to persist for years, a new study finds.
"Just ask the residents of Cordova today whether they are over the Exxon Valdez," said study co-author Liesel Ritchie, assistant director for research of the University of Colorado Boulder's Natural Hazards Center. The Alaska community was considered "ground zero" for the 1989 oil spill.
The research was a collaborative effort among Ritchie, ...
Homeowners facing foreclosure could see additional, although potentially short-term, relief from the Florida courts in the near future. Those with pending foreclosure actions that have not moved forward may see the case against them dismissed by the court because the bank has essentially abandoned the case or has not moved closer to concluding the action.
Courts across the country are perpetually overwhelmed with cases; judges often struggle to keep their dockets moving along in a timely manner. To address the number of cases and to ensure that courts do not get bogged ...
In today's modern families it is common for fathers and mothers to both play active roles in the parenting of their children. When these marriages come to an end, one of the most troublesome problems is the issue of where the children will live.
Illinois law provides two options to resolve custody disputes, namely Sole or Joint Custody. When applied traditionally either option unsatisfactorily results in the children residing primarily with one parent while the other parent exercises visitation and pays child support.
The response to this problem in Illinois family ...
New Orleans, LA –In the first animal model of Amyotrophic Lateral Sclerosis (ALS), developed by Dr. Udai Pandey, Assistant Professor of Genetics at LSU Health Sciences Center New Orleans, Dr. Pandey's lab has found in fruit flies that blocking the abnormal movement of a protein made by a mutated gene called FUS also blocks the disease process. The research is available online in the Advanced Access section of the journal Human Molecular Genetics website, posted on April 12, 2011. It will be published in an upcoming issue of the journal.
The fruit flies were engineered ...
Chicago's streets are home to almost 400 red light cameras that monitor 190 of the city's most dangerous intersections. The program began in 2003, when the city installed cameras at two intersections: 55th and Western, and Peterson and Western. Since then, the city has issued millions of violations--763,419 in 2010 alone--and made millions of dollars in revenue from the red light cameras.
The cameras are connected to the intersection's traffic lights. When the light turns red, any vehicle that passes under the sensor get its picture taken and is recorded on a video device. ...
Stanford researchers have developed a new biosensor microchip that could significantly speed up the process of drug development. The microchips, packed with highly sensitive "nanosensors," analyze how proteins bind to one another, a critical step for evaluating the effectiveness and possible side effects of a potential medication.
A single centimeter-sized array of the nanosensors can simultaneously and continuously monitor thousands of times more protein-binding events than any existing sensor. The new sensor is also able to detect interactions with greater sensitivity ...
